WASHINGTON--(BUSINESS WIRE)--Altoida, a pioneer in developing digital biomarkers of neurological disease using augmented reality (AR) and machine learning (ML), today announced results from a ...
Feasibility and Acceptability of Collecting Passive Smartphone Data for Potential Use in Digital Phenotyping Among Family Caregivers and Patients With Advanced Cancer Patients with locally advanced ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results